GSK3B and hepatocellular carcinoma: Chen et al. also reported that HJURP can promote hepatocellular carcinoma proliferation by destabilizing p21 via the MAPK/ERK1/2 and AKT/GSK3β signaling pathways (Chen et al., 2018).